Spatiotemporal Thalamocortical Alterations Underlie Experimental and Chronic Pain
Purpose
The purpose of this study is to assess thalamocortical (TC) connectivity during tonic
pressure pain, to evaluate alpha activity during tonic pressure pain and to determine
pressure pain ratings by using Electroencephalography (EEG), Functional Magnetic
Resonance Imaging (fMRI), Transcranial Alternating Current Stimulation (tACS), sham and
Transcranial random noise stimulation (tRNS)
Condition
Eligibility
- Eligible Ages
-
Between 18 Years and 60 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
-
Yes
Inclusion Criteria
- Meet the MRI / EEG screening criteria
- Fluent in English
Exclusion Criteria
- Current or history of major medical, neurological, or psychiatric illness based on
self-report
- History of cardiac, respiratory, or nervous system disease that, in the
investigator's judgment, precludes participation in the study because of a
heightened potential for adverse outcome (for example: asthma or claustrophobia)
- History of head trauma
- Pregnant or lactating
- Presence of any contraindications to MRI scanning (for example: cardiac pacemaker,
metal implants, claustrophobia, pregnancy, cannot lie still in fMRI scanner)
- Conditions making study participation difficult (e.g., paralysis, psychoses, or
other severe psychological problems as per the judgment of a study investigator
during Session 1)
- Active substance abuse disorders (based on subject self-report)
Study Design
- Phase
- N/A
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover Assignment
- Primary Purpose
- Basic Science
- Masking
- Triple (Participant, Care Provider, Investigator)
Arm Groups
| Arm | Description | Assigned Intervention |
Experimental tACS then tRNS then sham
|
|
-
Device: transcranial alternating current stimulation (tACS)
Participants will get a personalized brain stimulation: a 2 milliampere (mA) oscillating
current that matches their natural alpha brain wave frequency (8-12 Hz), determined by a
quick 3-minute EEG before the session.
-
Device: Sham
Active sham stimulation with 60- second -tACS will be applied , then ramp down, and be
reintroduced in the last 30 seconds to minimize awareness of the experimental condition
-
Device: transcranial random noise stimulation (tRNS)
Participants will still get stimulation, but at random frequencies between 1 and 200 Hz
(instead of targeted alpha waves).
|
Experimental tACS then sham then tRNS
|
|
-
Device: transcranial alternating current stimulation (tACS)
Participants will get a personalized brain stimulation: a 2 milliampere (mA) oscillating
current that matches their natural alpha brain wave frequency (8-12 Hz), determined by a
quick 3-minute EEG before the session.
-
Device: Sham
Active sham stimulation with 60- second -tACS will be applied , then ramp down, and be
reintroduced in the last 30 seconds to minimize awareness of the experimental condition
-
Device: transcranial random noise stimulation (tRNS)
Participants will still get stimulation, but at random frequencies between 1 and 200 Hz
(instead of targeted alpha waves).
|
Experimental tRNS then tACS then sham
|
|
-
Device: transcranial alternating current stimulation (tACS)
Participants will get a personalized brain stimulation: a 2 milliampere (mA) oscillating
current that matches their natural alpha brain wave frequency (8-12 Hz), determined by a
quick 3-minute EEG before the session.
-
Device: Sham
Active sham stimulation with 60- second -tACS will be applied , then ramp down, and be
reintroduced in the last 30 seconds to minimize awareness of the experimental condition
-
Device: transcranial random noise stimulation (tRNS)
Participants will still get stimulation, but at random frequencies between 1 and 200 Hz
(instead of targeted alpha waves).
|
Experimental tRNS then sham then tACS
|
|
-
Device: transcranial alternating current stimulation (tACS)
Participants will get a personalized brain stimulation: a 2 milliampere (mA) oscillating
current that matches their natural alpha brain wave frequency (8-12 Hz), determined by a
quick 3-minute EEG before the session.
-
Device: Sham
Active sham stimulation with 60- second -tACS will be applied , then ramp down, and be
reintroduced in the last 30 seconds to minimize awareness of the experimental condition
-
Device: transcranial random noise stimulation (tRNS)
Participants will still get stimulation, but at random frequencies between 1 and 200 Hz
(instead of targeted alpha waves).
|
Experimental Sham then tRNS then tACS
|
|
-
Device: transcranial alternating current stimulation (tACS)
Participants will get a personalized brain stimulation: a 2 milliampere (mA) oscillating
current that matches their natural alpha brain wave frequency (8-12 Hz), determined by a
quick 3-minute EEG before the session.
-
Device: Sham
Active sham stimulation with 60- second -tACS will be applied , then ramp down, and be
reintroduced in the last 30 seconds to minimize awareness of the experimental condition
-
Device: transcranial random noise stimulation (tRNS)
Participants will still get stimulation, but at random frequencies between 1 and 200 Hz
(instead of targeted alpha waves).
|
Experimental Sham then tACS then tRNS
|
|
-
Device: transcranial alternating current stimulation (tACS)
Participants will get a personalized brain stimulation: a 2 milliampere (mA) oscillating
current that matches their natural alpha brain wave frequency (8-12 Hz), determined by a
quick 3-minute EEG before the session.
-
Device: Sham
Active sham stimulation with 60- second -tACS will be applied , then ramp down, and be
reintroduced in the last 30 seconds to minimize awareness of the experimental condition
-
Device: transcranial random noise stimulation (tRNS)
Participants will still get stimulation, but at random frequencies between 1 and 200 Hz
(instead of targeted alpha waves).
|
Recruiting Locations
The University of Texas Health Science Center at Houston
Houston 4699066,
Texas 4736286
77030
More Details
- Status
- Recruiting
- Sponsor
- The University of Texas Health Science Center, Houston
Study Contact
Wen Li, PhD
(713) 486-2700
Wen.Li.1@uth.tmc.edu
Notice
Study information shown on this site is derived from
ClinicalTrials.gov (a public registry operated by the National Institutes of Health).
The listing of studies provided is not certain to be all studies for which you might be eligible.
Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.